These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12934937)
21. Targeted drug delivery to macrophages in parasitic infections. Owais M; Gupta CM Curr Drug Deliv; 2005 Oct; 2(4):311-8. PubMed ID: 16305434 [TBL] [Abstract][Full Text] [Related]
22. Disease-induced drug targeting using novel peptide-ligand albumins. Meijer DK; Beljaars L; Molema G; Poelstra K J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994 [TBL] [Abstract][Full Text] [Related]
23. Pharmaceutical approaches to colon targeted drug delivery systems. Chourasia MK; Jain SK J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729 [TBL] [Abstract][Full Text] [Related]
24. Intracellular Drug Delivery: Mechanisms for Cell Entry. Garnacho C Curr Pharm Des; 2016; 22(9):1210-26. PubMed ID: 26675221 [TBL] [Abstract][Full Text] [Related]
25. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides. Jones AT Int J Pharm; 2008 Apr; 354(1-2):34-8. PubMed ID: 18068916 [TBL] [Abstract][Full Text] [Related]
26. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
32. Cell-based assays in GPCR drug discovery. Siehler S Biotechnol J; 2008 Apr; 3(4):471-83. PubMed ID: 18383022 [TBL] [Abstract][Full Text] [Related]
33. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). Tanaka T; Shiramoto S; Miyashita M; Fujishima Y; Kaneo Y Int J Pharm; 2004 Jun; 277(1-2):39-61. PubMed ID: 15158968 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of nanocarriers with remote magnetic drug release control and enhanced drug delivery for intracellular targeting of cancer cells. Tung WL; Hu SH; Liu DM Acta Biomater; 2011 Jul; 7(7):2873-82. PubMed ID: 21439410 [TBL] [Abstract][Full Text] [Related]
35. Mannose-specific endocytosis receptor of alveolar macrophages: demonstration of two functionally distinct intracellular pools of receptor and their roles in receptor recycling. Tietze C; Schlesinger P; Stahl P J Cell Biol; 1982 Feb; 92(2):417-24. PubMed ID: 6277962 [TBL] [Abstract][Full Text] [Related]
36. Mannosylated Constructs as a Platform for Cell-Specific Delivery of Bioactive Agents. Tiwari S Crit Rev Ther Drug Carrier Syst; 2018; 35(2):157-194. PubMed ID: 29717665 [TBL] [Abstract][Full Text] [Related]
37. Oxidized carbon nanoparticles as an effective protein antigen delivery system targeting the cell-mediated immune response. Sawutdeechaikul P; Jiangchareon B; Wanichwecharungruang S; Palaga T Int J Nanomedicine; 2019; 14():4867-4880. PubMed ID: 31308663 [No Abstract] [Full Text] [Related]
38. Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages. Ahsan F; Rivas IP; Khan MA; Torres Suarez AI J Control Release; 2002 Feb; 79(1-3):29-40. PubMed ID: 11853916 [TBL] [Abstract][Full Text] [Related]
39. Movement of receptors and ligands through the endocytic apparatus in alveolar macrophages. Kaplan J; Ward DM Am J Physiol; 1990 Jun; 258(6 Pt 1):L263-70. PubMed ID: 2163207 [TBL] [Abstract][Full Text] [Related]
40. Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency. Sobolev AS Biochemistry (Mosc); 2009 Dec; 74(13):1567-74. PubMed ID: 20210709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]